[(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate

C50H58O6 — CID 46846171

IUPAC[(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
SMILES[2H]c1c([2H])c(C#C[C@]2(OC(C)=O)CC[C@H]3[C@@H]4CCC5=CC(=O)CC[C@@H]5[C@H]4CC[C@@]32C)c([2H])c([2H])c1C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C
InChIInChI=1S/C50H58O6/c1-31(51)55-49(27-21-45-43-13-9-35-29-37(53)11-15-39(35)41(43)19-23-47(45,49)3)25-17-33-5-7-34(8-6-33)18-26-50(56-32(2)52)28-22-46-44-14-10-36-30-38(54)12-16-40(36)42(44)20-24-48(46,50)4/h5-8,29-30,39-46H,9-16,19-24,27-28H2,1-4H3/t39-,40-,41+,42+,43+,44+,45-,46-,47-,48-,49-,50-/m0/s1/i5D,6D,7D,8D
InChIKeyOLQXCLBFCGSXKK-YDLMQESASA-N
MW759.03 g/mol
LogP9.28
Rot. Bonds2

About [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate

[(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate (PubChem CID 46846171) has the molecular formula C50H58O6 and a molecular weight of 759.03 g/mol. Its IUPAC name is [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate.

Molecular Properties

Compound Name[(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
PubChem CID46846171
Molecular FormulaC50H58O6
Molecular Weight759.03 g/mol
Exact Mass758.45
IUPAC Name[(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
SMILES[2H]c1c([2H])c(C#C[C@]2(OC(C)=O)CC[C@H]3[C@@H]4CCC5=CC(=O)CC[C@@H]5[C@H]4CC[C@@]32C)c([2H])c([2H])c1C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C
InChIInChI=1S/C50H58O6/c1-31(51)55-49(27-21-45-43-13-9-35-29-37(53)11-15-39(35)41(43)19-23-47(45,49)3)25-17-33-5-7-34(8-6-33)18-26-50(56-32(2)52)28-22-46-44-14-10-36-30-38(54)12-16-40(36)42(44)20-24-48(46,50)4/h5-8,29-30,39-46H,9-16,19-24,27-28H2,1-4H3/t39-,40-,41+,42+,43+,44+,45-,46-,47-,48-,49-,50-/m0/s1/i5D,6D,7D,8D
InChIKeyOLQXCLBFCGSXKK-YDLMQESASA-N
XLogP9.28
TPSA86.74 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds2
Heavy Atoms56
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500759.03
LogP ≤ 59.28
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] nitrate
CID 88673718
(8R,9S,10R,13S,14R,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CID 124903834
[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] azete-2-carboxylate
CID 56612891
[(8R,9S,10R,13S,14S,16R,17R)-17-acetyl-13,16-dimethyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
CID 22213187
(8R,9S,10R,13S,14R,17S)-17-hydroxy-17-[4-[(8S,9S,10S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]buta-1,3-diynyl]-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CID 125125214
[(9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
CID 19688
acetic acid;(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CID 87060263
acetic acid;(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CID 146676005
(8R,9S,13S,14S,17S)-17-buta-1,3-diynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CID 118796854
(17R)-17-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CID 6432525
(8R,9S,10R,13S,14S,17S)-17-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CID 5858
(8R,9S,10R,13S,14S,17S)-17-hydroxy-17-(2-iodoethynyl)-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CID 70475653

Frequently Asked Questions

What is the IUPAC name of [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate?
The IUPAC name of [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate (CID 46846171) is [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate.
What is the SMILES notation for [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate?
The canonical SMILES for [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate is [2H]c1c([2H])c(C#C[C@]2(OC(C)=O)CC[C@H]3[C@@H]4CCC5=CC(=O)CC[C@@H]5[C@H]4CC[C@@]32C)c([2H])c([2H])c1C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C.
What is the InChIKey of [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate?
The InChIKey is OLQXCLBFCGSXKK-YDLMQESASA-N. The full InChI is InChI=1S/C50H58O6/c1-31(51)55-49(27-21-45-43-13-9-35-29-37(53)11-15-39(35)41(43)19-23-47(45,49)3)25-17-33-5-7-34(8-6-33)18-26-50(56-32(2)52)28-22-46-44-14-10-36-30-38(54)12-16-40(36)42(44)20-24-48(46,50)4/h5-8,29-30,39-46H,9-16,19-24,27-28H2,1-4H3/t39-,40-,41+,42+,43+,44+,45-,46-,47-,48-,49-,50-/m0/s1/i5D,6D,7D,8D.
What are the key properties of [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate?
[(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate has a molecular weight of 759.03 g/mol, XLogP of 9.28, 2 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [(8R,9S,10R,13S,14S,17S)-17-[2-[4-[2-[(8R,9S,10R,13S,14S,17S)-17-acetyloxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethynyl]-2,3,5,6-tetradeuteriophenyl]ethynyl]-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate is sourced from PubChem (CID 46846171), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).